Literature DB >> 5313264

Development of organophosphorus resistance in Indian strains of Aedes aegypti (L.).

B V Madhukar, M K Pillai.   

Abstract

Populations of the yellow-fever mosquito, Aedes aegypti, have developed resistance to cholorinated hydrocarbons in many parts of the world, but not to organophosphorus insecticides. Seven Indian strains of Ae. aegypti were found to be tolerant to DDT and highly susceptible to certain organophosphorus compounds such as Abate, Dursban, fenthion and fenitrothion. Hence selection studies were started with these organophosphorus compounds. Laboratory selections on these strains for 20 generations with Abate, Dursban, malathion, fenthion and fenitrothion increased the tolerance of the F(20) larvae to these insecticides by 2.4 times, 3.7 times, 3 times, 5.6 times and 2 times, respectively. The dosage-mortality lines of the successive generations were steep and parallel, suggesting these were instances of tolerance and not of resistance. In contrast, DDT selection showed rapid changes in dosage-mortality lines, indicating the development of resistance. The organophosphorus selected strains generally showed only a 2-3-fold increase in cross-tolerance to other organophosphorus compounds.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5313264      PMCID: PMC2427799     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  3 in total

1.  PHYSIOLOGICAL AND GENETICAL STUDIES ON RESISTANCE TO DDT SUBSTITUTES IN AEDES AEGYPTI.

Authors:  M K PILLAI; A W BROWN
Journal:  J Econ Entomol       Date:  1965-04       Impact factor: 2.381

2.  [Resistance to insecticides in Culex pipiens fatigans Wied. and problems of urban hygiene in the Cameroons].

Authors:  J MOUCHET; R ELLIOT; J GARIOU; J VOELCKEL; J VARRIERAS
Journal:  Med Trop (Mars)       Date:  1960 Jul-Aug

3.  Development of resistance to various insecticides in Culex pipiens fatigans Wiedemann.

Authors:  T Tadano; A W Brown
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.